Agrawal S. Yao TJ. Coit DG. Surgery for melanoma metastatic to the gastrointestinal tract. Annals of Surgical Oncology. 1999:336-44.
[PubMed Abstract]
Agus DB. Scher HI. Higgins B. Fox WD. Heller G. Fazzari M. Cordon-Cardo C. Golde DW. Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and independent human xenograft models. Cancer Research. 1999;59:4761-4764.
[PubMed Abstract]
Amar D, Zhang H, Leung, DHY, Ginsburg, I. Effects of left and right pneumonectomy on time-and frequency-domain parameters of heart rate variability. Annals of Noninvasive Electrocardiology 1999;4:325-332.
Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer (with editorial). New England Journal of Medicine 1999;341:1198-1205.
[PubMed Abstract]
Bajorin DF, Dodd PM, Mazumdar M, Fazzari M, McCaffrey JA, Scher HI, Herr H, Higgins G, Boyle MG. Long-term survival in metastatic transitional cell carcinoma and prognostic factors predicting outcome of therapy. Journal of Clinical Oncology. 1999;17:3173-3181
[PubMed Abstract]
Barakat RR, Goldman NA, Patel DA, Venkatraman ES, Curtin JP. Pelvic exenteration for recurrent endometrial cancer. Gynecologic Oncology 1999;75:99-102.
[PubMed Abstract]
Barrera R, Melendez J, Ahdoot M, Huang Y, Leung D, Groeger JS. Flow triggering added to pressure support ventilation improves comfort and reduces work of breathing in mechanically ventilated patients. Journal of Critical Care 1999;14:172-176.
[PubMed Abstract]
Begg CB: Methodological and statistical considerations in the study of multiple primary cancers. In: Multiple Primary Cancers. Eds. Neugut A, Meadows A, Robinson E. Lippincott, Williams and Wilkins, Baltimore, 1999, pp13-26.
Begg CB, Cramer LD, Hoskins WJ, Brennan MF: Response to correspondence. Journal of the American Medical Association 1999;281:1375.
Begg MD, Panageas KS. Interval estimation of the common odds ratio from k(2x2) tables under cluster sampling. Statistics in Medicine 1999;18:1087-1100.
[PubMed Abstract]
Berg WJ, Nanus DM, Leung A, Brown KT, Hutchinson B, Mazumdar M, Xu X-C, Lotan R, Reuter VE, Motzer RJ. Up-regulation of retinoic acid receptor beta expression in renal cancers in vivo correlates with response to 13-cis-retinoic acid and interferon-a-2a. Clinical Cancer Research 1999;5:1671-1675.
[PubMed Abstract]
Berg WJ, Mc Caffrey J, Schwartz LH, Mariani T, Mazumdar M, Motzer RJ. A phase-II study of pyrazoloacridine in patients with advanced renal-cell carcinoma. Inv New Dr 1999;16:337-340
[PubMed Abstract]
Bhat A, Heath SC, Ott J. (1999). Heterogeneity for multiple disease loci in linkage analysis. Human Heredity, 49:229-231.
[PubMed Abstract]
Billingsley KG, Burt ME, Jara E, Ginsberg RJ, Woodruff JM, Leung DHY, Brennan MF. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of disease and postmetastasis survival. Annals of Surgery 1999;229:602-612.
[PubMed Abstract]
Billingsley KG, Lewis JJ, Leung DHY, Casper ES, Woodruff JM, Brennan MF. Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma. Cancer 1999;85:389-395.
[PubMed Abstract]
Casper ES, Schwartz GM, Leung D, Sugarman A, Bertino JR. Evaluation of dose-intense ifosfamide, with and without edatrexate, in adults with sarcoma. Sarcoma 1999;3:121-127
Chapman PB, Einhorn LH, Meyers ML, Saxman S, Destro AN, Panageas KS, Begg CB, Agarwala SS, Schuchter LM, Ernstoff MS, Houghton AN, Kirkwood JM. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. Journal of Clinical Oncology. 1999; 17: 2745-2751.
[PubMed Abstract]
Cheung IY, Cheung N-KV, Ghossein RA, Satagopan JM, Bhattacharya S, Coit DG (1999): Association between molecular detection of GAGE and survival in patients with malignant melanoma: a retrospective cohort study. Clinical Cancer Research 5:2042-2047.
[PubMed Abstract]
D'Andrea G. Fennelly D. Norton L. Baselga J. Gilewski T. Hudis C. Moynahan ME. Raptis G. Sklarin N. Surbone A. Theodoulou M. Templeton MA. Yao TJ. Seidman AD. Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer. Clinical Cancer Research. 1999; 5:275-279.
[PubMed Abstract]
Dansky HM, Charlton SA, Sikes JL, Heath SC, Simantov R, Levin LF, Shu P, Moore KJ, Breslow JL, Smith JD. (1999). Genetic background determines the extent of Atherosclerosis in Apolipoprotein E deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 19:1960-1968.
[PubMed Abstract]
Daw EW, Heath SC, & Wijsman EM. (1999). Multipoint oligogenic analysis of age-of-onset data with applications to Alzheimer's disease pedigrees. American Journal of Human Genetics, 64:839-851.
[PubMed Abstract]
Disa JJ, Hidalgo DA, Cordeiro PG, Winters RM, Thaler H. Evaluation of bone height in osseous free-flap madible reconstruction - an indirect measure of bone mass. Plas R Surg 103:1371-1377, 1999.
[PubMed Abstract]
Dodd PM, McCaffrey JA, Herr H, Mazumdar M, Bacik J, Higgins G, Boyle MG, Scher HI, Bajorin DF. Outcome of post-chemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional-cell carcinoma. Journal of Clinical Oncology. 1999;17: 2546-2552.
[PubMed Abstract]
Fishman J, Reynold T, Riedel E. A retrospective investigation of an intensive outpatient substance abuse treatment program. American J of Drug & Alcohol Abuse 1999;25:185-196.
[PubMed Abstract]
Fokianos K, Peng A, Qin J. A generalized moments specification test of the link function in case-control studies. Canadian Journal Stats 1999;27:735-750.
Gemignani ML, Curtin JP, Zelmanovich J, Patel A, Venkatraman E, Barakat RR (1999). Laparoscopic-assisted vaginal hysterectomy for endometrial cancer: clinical outcomes and hospital charges. Gynecologic Oncology 73:5-11.
[PubMed Abstract]
Ghossein RA. Osman I. Bhattacharya S. Ferrara J. Fazzari M. Cordon-Cardo C. Scher HI. Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction. Diagnostic Molecular Pathology. 1999;8:59-65.
[PubMed Abstract]
Gordon D, Heath SC, & Ott J. (1999) True pedigree errors more frequent than apparent errors for single nucleotide polymorphisms. Human Heredity, 49:65-70.
Gordon D, Matise TC, Heath SC & Ott J. (1999). Effects of random genotype errors on power of multi-allelic transmission disequilibrium test: A study using GAW11 simulated data. Genetic Epidemiology, 17 Suppl.1:S587-592.
[PubMed Abstract]
Groeger JS. White P Jr. Nierman DM. Glassman J. Shi W. Horak D. Price K. Outcome for cancer patients requiring mechanical ventilation. Journal of Clinical Oncology. 1999;17:991-997.
[PubMed Abstract]
Guillem JG. Puig-La Calle J Jr. Cellini C. Murray M. Ng J. Fazzari M. Paty PB. Quan SH. Wong WD. Cohen AM. Varying features of early age-of-onset "sporadic" and hereditary nonpolyposis colorectal cancer patients. Diseases of the Colon & Rectum. 1999;4236-42.
[PubMed Abstract]
Hann LE. Bach AM. Cramer LD. Siegel D. Yoo HH. Garcia R. Hepatic sonography: comparison of tissue harmonic and standard sonography techniques. American Journal of Roentgenology. 1999;173:201-206.
[PubMed Abstract]
Harrison H, Fixsen A, Vickers AJ. A randomized comparison of homoeopathic and standard care for the treatment of glue ear in children. Complementary Therapies in Medicine 1999;7(3):132-5.
[PubMed Abstract]
Heelan RT, Rusch VW, Begg CB, Panicek DM, Caravelli JF, Eisen C: Computed tomography and magnetic resonance imaging staging of malignant pleural mesothelioma. Am J Roentg 1999;172:1039-1047.
[PubMed Abstract]
Hudis C, Fornier M, Riccio L, Lebwohl D, Crown J, Gilewski T, Surbone A, Currie V, Seidman A, Reichman B, Moynahan M, Raptis G, Sklarin N, Theodoulou M, Weiselberg L, Salvaggio R, Panageas KS, Yao TJ, Norton L. 5-year results of dose-intensive sequential adjuvant chemotherapy for women with high risk node positive breast cancer: a phase II study. Journal of Clinical Oncology. 1999;17:1118-1126.
[PubMed Abstract]
Hudis C. Seidman A. Baselga J. Raptis G. Lebwohl D. Gilewski T. Moynahan M. Sklarin N. Fennelly D. Crown JP. Surbone A. Uhlenhopp M. Riedel E. Yao TJ. Norton L. Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: feasibility and efficacy. Journal of Clinical Oncology. 1999;17:93-100.
[PubMed Abstract]
Husain A, Sabbatini P, Spriggs D, Fennelly D, Aghajanian C, Barakat R, Curtin J, Venkatraman E, Hoskins, Markman M. (1999) Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer. Gynecologic Oncology 73:96-101.
[PubMed Abstract]
Ilson DH, Saltz L, Enzinger P, Huang Y, Kornblith A, Gollub M, O'Reilly E, Schwartz G, DeGroff J, Gonzalez G, Kelsen DP. Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol 1999;17:3270-3275.
[PubMed Abstract]
Johnson WG, Stenroos ES, Heath SC, Chen Y, Carroll R, McKoy VV, Chatkupt S, Lehner T. (1999). Distribution of alleles of a methylenetetrahydrofolate reductase (MTHFR) gene polymorphism in familial spina bifida. Medical Genetics, 87:407-412.
[PubMed Abstract]
Kattan MW, Miles BJ. The patients' choice of surgery for clinically localized prostate cancer. In Vaughan Jr. ED and Perlmutter AP, eds. Atlas of Clinical Urology. London: Churchill Livingstone, 1999:9.1-9.7.
Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, Bertino JR, Turnbull ADM, Sullivan D, Stockman J, Blumgart LH, Fong Y. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. The New England Journal of Medicine 1999; 341:2039-2048.
[PubMed Abstract]
Kim SH, Karpeh MS, Klimstra DS, Leung D, Brennan MF. Effect of microscopic resection line disease on gastric-cancer survival. J Gastro S 1999;3:24-33.
[PubMed Abstract]
Kourea HP, Cordon-Cardo C, Dudas M, Leung D, Woodruff JM. Expression of P27(KIP) and other cell-cycle regulators in malignant peripheral-nerve sheath tumors and neurofibromas - the emerging role of P27(KIP) in malignant transformation of neurofibromas. American Journal of Pathology 1999;155:1885-1891.
[PubMed Abstract]
Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac H, Finn RD, Casilla C, Fazzari M, Srivastavan N, Yeung H, Humm J, Guillem J, Downey R, Karpeh M, Cohen AE, Ginsberg R. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging: The visual response score (VRS), and the change in total lesion glycolysis (dTLG). Clinical Positron Imaging. Clinical Positron Imaging 1999;2:159-171.
Leal, S. & S.C. Heath (1999). Markov chain Monte Carlo methods detect susceptibility loci on chromosomes 11 and 4. Genetic Epidemiology, 17, Suppl.1:S217-222.
[PubMed Abstract]
Lee CT. Capodieci P. Osman I. Fazzari M. Ferrara J. Scher HI. Cordon-Cardo C. Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer. Clinical Cancer Research. 1999;5:977-983.
[PubMed Abstract]
Lewis JJ, Leung D, Casper ES, Woodruff J, Hajdu SI, Brennan MF. Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma. Arch Surg 1999;85:190-194.
[PubMed Abstract]
Lewis JJ, Boland PJ, Leung DHY, Woodruff JM, Brennan MF. The enigma of desmoid tumors. Annals of Surgery 1999;229:866-872.
[PubMed Abstract]
Melchart D, Linde K, Fischer P, White A, Allais G, Vickers AJ, Berman B. Acupuncture for chronic headache: a systematic review of randomized controlled trials. Cephalalgia. 1999;19:779-86.
[PubMed Abstract]
Merchant NB, Lewis JJ, Woodruff JM, Leung DHY, Brennan MF. Extremity and trunk desmoid tumors - a multifactorial analysis of outcome. Cancer 1999;86:2045-2052.
[PubMed Abstract]
Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 1999;17:2530-2540.
[PubMed Abstract]
Nasi LN, Lieberman P, Busam K, Prieto V, Panageas KS, Lewis JJ, Houghton AN, Chapman PB. Intradermal injection of granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with metastatic melanoma. Cytokines, Cellular & Molecular Therapy 1999;5:139-144.
[PubMed Abstract]
Osman I. Drobnjak M. Fazzari M Ferrara J. Scher HI. Cordon-Cardo C. Inactivation of the p53 pathway in prostate cancer: impact on tumor progression. Clinical Cancer Research. 1999;5:2082-2088.
[PubMed Abstract]
Pasche B, Kolachana P, Nafa Khedoudja, Satagopan J, Chen Y-G, Lo RS, Brener D, Yang D, Kirstein L, Oddoux C, Ostrer H, Jhanwar S, Luzzatto L, Massague J, Offit K (1999): TßR-I(6A) is a candidate tumor susceptibility allele. Cancer Research 59:5678-5682.
[PubMed Abstract]
Potters L, Cha C, Oshinsky G, Venkatraman E, Zelefsky M, Leibel S. Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy. Ca J Sci Am 1999;5:301-306.
[PubMed Abstract]
Qin J. Empirical likelihood ratio based confidence intervals for mixture proportions. Ann of Stats 1999;27:1368-1384.
Robson M, Levin D, Federici M, Satagopan J, Bogolminy F, Heerdt A, Borgen P, McCormick B, Hudis C, Norton L, Boyd J, Offit K. Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations. JNCI 1999;91:2112-2117.
[PubMed Abstract]
Rusch VW, Venkatraman ES. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac 1999;68:1799-1804.
[PubMed Abstract]
Salo JC, Lewis JJ, Woodruff JM, Leung DH, Brennan MF. Malignant fibrous histiocytoma of the extremity. Cancer 1999;85:1765-1772.
[PubMed Abstract]
Scardino PT, Wheeler TM, Kattan MW. Is cure of prostate cancer possible in those for whom it is necessary? In Kurth KH, Mickisch GH and Schoder FH, eds. Renal Bladder and Prostate Cancer: An Update. New York:Parthenon, 1999:131-137.
Schrag D, Weeks JC. Costs and cost-effectiveness of colorectal cancer prevention and therapy. Semin Oncol. 1999; 26: 561-568.
[PubMed Abstract]
Sheu K-FR, Brown AM, Haroutunian V, Kristal BS, Thaler H, Lesser M, Kalaria RN, Relkin NR, Mohs, RC, Lilius L, Lannfelt L, Blass JP. Modulation by DLST of the genetic risk of Alzheimer=s disease in a very elderly population. Annals of Neurology 45:48-53, 1999.
[PubMed Abstract]
Slovin SF. Ragupathi G. Adluri S. Ungers G. Terry K. Kim S. Spassova M. Bornmann WG. Fazzari M. Dantis L. Olkiewicz K. Lloyd KO. Livingston PO. Danishefsky SJ. Scher HI. Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man. Proceedings of the National Academy of Sciences of the United States of America. 1999;96:5710-5715.
[PubMed Abstract]
Small TN. Papadopoulos EB. Boulad F. Black P. Castro-Malaspina H. Childs BH. Collins N. Gillio A. George D. Jakubowski A. Heller G. Fazzari M. Kernan N. MacKinnon S. Szabolcs P. Young JW. O'Reilly RJ. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood. 1999;93:467-480.
[PubMed Abstract]
Thompson EA. & Heath SC. (1999). Estimation of conditional multilocus gene identity among relatives. In Statistics in Molecular Biology ed. F. Seillier-Moseiwitch, P. Donnelly and M. Waterman. Springer-Verlag IMS lecture note series; New York.
Venkatraman ES, Begg CB. Properties of a nonparametric test for early comparison of treatments in clinical trials in the presence of surrogate endpoints. Biometrics 1999;55:1171-1176.
[PubMed Abstract]
Vickers AJ. Independent replication of pre-clinical research in homoeopathy: a systematic review. Forschende Komplementärmedizin 1999;6:311-20.
[PubMed Abstract]
Vickers AJ. National health service funding for complementary medicine research (editorial). Complementary Therapies in Medicine 1999;7:1-2.
[PubMed Abstract]
Vickers AJ. Evidence-based medicine and complementary medicine. Evidence-Based Mental Health 1999;2(4):102-3.
Vickers AJ, Rees RW, Zollman CE, Smith C, Ellis N. Acupuncture for migraine and headache in primary care: a protocol for a pragmatic, randomised trial. Complementary Therapies in Medicine 1999;7:3-18.
[PubMed Abstract]
Vickers A. Complementary medicine or antagonistic medicine? Complementary Therapies in Medicine 1999;7:125.
[PubMed Abstract]
Vickers A. Reflections on complementary medicine research in the UK. Complementary Therapies in Medicine 1999;7(4):199-200.
[PubMed Abstract]
Vickers A. Guidelines for authors of books and papers on complementary medicine. Complementary Therapies in Medicine 1999;7(4):245-9.
[PubMed Abstract]
Vickers AJ, Zollman CE. ABC of complementary medicine: Acupuncture. British Medical Journal 1999;319:973-6.
[PubMed Abstract]
Vickers AJ, Zollman CE. ABC of complementary medicine: Herbal medicine. British Medical Journal 1999;319:1050-3.
[PubMed Abstract]
Vickers AJ, Zollman CE. ABC of complementary medicine: Homoeopathy. British Medical Journal 1999;319:1115-8.
[PubMed Abstract]
Vickers AJ, Zollman CE. ABC of complementary medicine: The manipulative therapies: osteopathy and chiropractic. British Medical Journal 1999;319:1176-9.
[PubMed Abstract]
Vickers AJ, Zollman CE. ABC of complementary medicine: Massage therapies. British Medical Journal 1999;319:1254-7.
[PubMed Abstract]
Vickers AJ, Zollman CE. ABC of complementary medicine: Hypnosis and relaxation therapies. British Medical Journal 1999;319:1346-9.
[PubMed Abstract]
Vickers AJ. Comparison of an ordinal and a continuous measure of muscle soreness. International Journal of Technology Assessment in Health Care 1999;15:709-16.
[PubMed Abstract]
Visscher, PM. Haley CS, Heath SC, Muir WJ, & Blackwood DHR. (1999). Detecting QTLs for uni and bipolar disorder using a variance component method. Psychiatric Genetics, 19:75-84.
Wang S, Bartido S, Yang G, Qin J, Moroi Y, Panageas KS, Lewis JL, Houghton AN. A role for a melanosome transport signal in accessing the MHC class II presentation pathway and eliciting CD4+ T cell responses. Journal of Immunology 1999;163:5820-5826.
[PubMed Abstract]
Yao TJ. Meyers M. Livingston PO. Houghton AN. Chapman PB. Immunization of melanoma patients with BEC2-keyhole limpet hemocyanin plus BCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti-GD3 ganglioside antibodies. Clinical Cancer Research. 1999;5:77-81.
[PubMed Abstract]
Zelefsky MJ, Cowen D, Fuks Z, Shike M, Burman C, Jackson A, Venkatraman ES, Leibel SA (1999). Long-term tolerance of high-dose 3-dimensions conformal radiotherapy in patients with localized prostate carcinoma. Cancer 85:2460-2468.
[PubMed Abstract]
Zollman CE, Vickers AJ. ABC of complementary medicine: Unconventional approaches to nutritional medicine. British Medical Journal 1999;319:1419-22.
[PubMed Abstract]
Zollman CE, Vickers AJ. ABC of complementary medicine: Complementary medicine and the patient. British Medical Journal 1999;319:1486-9.
[PubMed Abstract]
Zollman CE, Vickers AJ. ABC of complementary medicine: What is complementary medicine?. British Medical Journal 1999;319:693-6.
[PubMed Abstract]
Zollman CE, Vickers AJ. ABC of complementary medicine: Users and practitioners of complementary medicine. British Medical Journal 1999;319:836-8.
[PubMed Abstract]
Zollman CE, Vickers AJ. ABC of complementary medicine: Complementary medicine in conventional practice. British Medical Journal 1999;319:901-4.
[PubMed Abstract]
Zollman CE, Vickers AJ. ABC of complementary medicine: Complementary medicine and the doctor. British Medical Journal 1999;319:1558-61.
[PubMed Abstract]
